The Centers for Medicare & Medicaid Services (CMS) recently announced a new initiative aimed at lowering prescription drug spending in Medicaid and improving health outcomes by increasing access to critical medications.
Medicaid programs that choose to participate in the GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) Model will be able to purchase drugs included in the pilot at prices aligned with those paid in select other countries.
The model will launch in January 2026 and run for five years. State Medicaid agencies interested in participating in this model will need to submit letters of intent to CMS and then later will have the opportunity to formally apply.
For more information on the GENEROUS Model, visit https://www.cms.gov/priorities/innovation/innovation-models/generous.